Literature DB >> 8200852

Lethal midline granuloma in Okinawa with special emphasis on polymorphic reticulosis.

S Kojya1, T Itokazu, N Maeshiro, H Esu, Y Noda, K Mishima, M Ohsawa, K Aozasa.   

Abstract

Lethal midline granuloma (LMG) is a clinical term used to describe a condition which may be manifested histologically as Wegener's granulomatosis (WG), polymorphic reticulosis (PR), and malignant lymphoma (ML). WG is an inflammatory disease, and PR and ML are considered to represent a neoplastic proliferation of lymphoreticular cells. In this report, twenty-two cases of LMG in Okinawa were examined. The frequency of LMG per 100,000 outpatients of the ear, nose and throat clinic in Okinawa was 67, and the higher frequency of PR (27) and ML (34) in Okinawa than in other districts of Japan was characteristic. Polymerase chain reaction, in situ hybridization, and immunohistochemical studies showed that the proliferating cells in PR were CD43+ and simultaneously contained Epstein-Barr viral genome in their nuclei. The higher frequency of PR and ML in Okinawa is discussed in conjunction with a review of pertinent literature: multiple factors including genetic, viral environmental, and socioeconomic factors seem to affect the frequencies of these diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200852      PMCID: PMC5919472          DOI: 10.1111/j.1349-7006.1994.tb02371.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  9 in total

1.  Lethal midline granuloma in Seoul (Korea) and Shanghai (China)

Authors:  K Aozasa; W J Yang; Y B Lee; W S Pan; Y F Wy; K Horiuchi; B H Hyun; K Tajima
Journal:  Int J Cancer       Date:  1992-10-21       Impact factor: 7.396

2.  Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma.

Authors:  Y Harabuchi; N Yamanaka; A Kataura; S Imai; T Kinoshita; F Mizuno; T Osato
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

3.  Association of Epstein-Barr virus with polymorphic reticulosis.

Authors:  M Furukawa; H Sakashita; Y Kimura; R Umeda
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

4.  Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection.

Authors:  D A Arber; L M Weiss; P F Albújar; Y Y Chen; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

5.  Expression of natural killer cell markers in non-Hodgkin's lymphomas.

Authors:  C S Ng; J K Chan; S T Lo
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

6.  Detection of low copy numbers of Epstein-Barr virus by in situ hybridization using nonradioisotopic probes prepared by the polymerase chain reaction.

Authors:  K Saeki; K Mishima; K Horiuchi; S Hirota; S Nomura; Y Kitamura; K Aozasa
Journal:  Diagn Mol Pathol       Date:  1993-06

7.  Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas.

Authors:  L M Weiss; L J Picker; T M Grogan; R A Warnke; J Sklar
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

8.  Nation-wide study of lethal mid-line granuloma in Japan: frequencies of wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions.

Authors:  K Aozasa; M Ohsawa; K Tajima; R Sasaki; H Maeda; T Matsunaga; I Friedmann
Journal:  Int J Cancer       Date:  1989-07-15       Impact factor: 7.396

9.  Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization.

Authors:  H Uhara; Y Sato; K Mukai; I Akao; Y Matsuno; S Furuya; T Hoshikawa; Y Shimosato; T Saida
Journal:  Jpn J Cancer Res       Date:  1990-03
  9 in total
  2 in total

Review 1.  Nasal NK/T-cell lymphoma: epidemiology and pathogenesis.

Authors:  Katsuyuki Aozasa; Tetsuya Takakuwa; Tadashi Hongyo; Woo-Ick Yang
Journal:  Int J Hematol       Date:  2008-02-08       Impact factor: 2.490

2.  Site-specific localization of Epstein-Barr virus in pharyngeal carcinomas.

Authors:  S Kojya; T Itokazu; Y Noda; M Ezaki; Y Tomita; M Ohsawa; K Aozasa
Journal:  Jpn J Cancer Res       Date:  1998-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.